QIAGEN Revenue 2006-2021 | QGEN

QIAGEN annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • QIAGEN revenue for the quarter ending September 30, 2021 was $0.535B, a 10.54% increase year-over-year.
  • QIAGEN revenue for the twelve months ending September 30, 2021 was $2.240B, a 30.83% increase year-over-year.
  • QIAGEN annual revenue for 2020 was $1.87B, a 22.53% increase from 2019.
  • QIAGEN annual revenue for 2019 was $1.526B, a 1.64% increase from 2018.
  • QIAGEN annual revenue for 2018 was $1.502B, a 5.95% increase from 2017.
QIAGEN Annual Revenue
(Millions of US $)
2020 $1,870
2019 $1,526
2018 $1,502
2017 $1,418
2016 $1,338
2015 $1,281
2014 $1,345
2013 $1,302
2012 $1,254
2011 $1,170
2010 $1,087
2009 $1,010
2008 $893
2007 $650
2006 $466
2005 $398
QIAGEN Quarterly Revenue
(Millions of US $)
2021-09-30 $535
2021-06-30 $567
2021-03-31 $567
2020-12-31 $571
2020-09-30 $484
2020-06-30 $443
2020-03-31 $372
2019-12-31 $413
2019-09-30 $383
2019-06-30 $382
2019-03-31 $349
2018-12-31 $403
2018-09-30 $378
2018-06-30 $377
2018-03-31 $344
2017-12-31 $397
2017-09-30 $364
2017-06-30 $349
2017-03-31 $308
2016-12-31 $367
2016-09-30 $339
2016-06-30 $334
2016-03-31 $298
2015-12-31 $349
2015-09-30 $315
2015-06-30 $319
2015-03-31 $298
2014-12-31 $360
2014-09-30 $336
2014-06-30 $331
2014-03-31 $317
2013-12-31 $361
2013-09-30 $322
2013-06-30 $315
2013-03-31 $304
2012-12-31 $347
2012-09-30 $304
2012-06-30 $307
2012-03-31 $296
2011-12-31 $334
2011-09-30 $289
2011-06-30 $282
2011-03-31 $264
2010-12-31 $286
2010-09-30 $274
2010-06-30 $263
2010-03-31 $264
2009-12-31 $289
2009-09-30 $260
2009-06-30 $240
2009-03-31 $221
2008-12-31 $237
2008-09-30 $231
2008-06-30 $218
2008-03-31 $207
2007-12-31 $210
2007-09-30 $177
2007-06-30 $135
2007-03-31 $128
2006-12-31 $126
2006-09-30 $118
2006-06-30 $113
2006-03-31 $109
2005-12-31 $104
2005-09-30 $99
2005-06-30 $100
2005-03-31 $95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.874B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.477B 7.93
Bio-Rad Laboratories (BIO.B) United States $23.034B 46.74
Biohaven Pharmaceutical Holding (BHVN) United States $7.457B 0.00
Arcus Biosciences (RCUS) United States $3.257B 0.00
Emergent Biosolutions (EBS) United States $2.378B 8.55
Myovant Sciences (MYOV) United Kingdom $1.780B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.529B 0.00
Zymeworks (ZYME) Canada $0.908B 0.00
Ambrx Biopharma (AMAM) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.10